Is the LAATS (Leptospira Antibody Agglutination Test System) used for diagnosing leptospirosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

LAATS is NOT a recognized diagnostic test for leptospirosis

The term "LAATS" (Leptospira Antibody Agglutination Test System) does not appear in any established guidelines or medical literature for leptospirosis diagnosis. You may be confusing this with either the Microscopic Agglutination Test (MAT), which is the reference standard, or the Latex Agglutination Test (LAT), which is a rapid bedside diagnostic tool.

Established Diagnostic Tests for Leptospirosis

Gold Standard: Microscopic Agglutination Test (MAT)

For definitive diagnosis, convalescent serology >10 days after symptom onset should include IgM ELISA and MAT 1. The MAT requires:

  • An IgM titer ≥1:320 is considered suggestive of leptospirosis
  • Titers of 1:80 to 1:160 are consistent with early infection but may represent cross-reactions
  • Paired acute and convalescent samples increase sensitivity to 68% (95% CrI 32-92%) 2

Critical limitation: Single acute-phase MAT has poor sensitivity of only 14% (95% CrI 3-38%) 2, making it inadequate for early diagnosis.

Alternative: Latex Agglutination Test (LAT)

LAT using recombinant LigA/B or LipL32 antigens serves as a rapid point-of-care test with superior early-phase sensitivity compared to single acute MAT 3, 4, 5. Key performance characteristics:

  • Sensitivity: 90.62-99.5% in early infection 3, 4
  • Specificity: 86.66-92.31% 3, 6, 4
  • Turnaround time: Results within minutes
  • Stability: Latex beads stable at 4°C for >3 months 5

LAT is particularly valuable in remote locations where MAT is not accessible 3 and can detect antibodies during the acute phase when MAT sensitivity is lowest 5.

Diagnostic Algorithm

Early Phase (<10 days from symptom onset):

  1. Blood culture (within first 5 days, before antibiotics) - transfer at room temperature to reference laboratory 1
  2. LAT or IgM ELISA for rapid screening 3, 4
  3. CSF culture if meningeal signs present 1

Late Phase (>10 days from symptom onset):

  1. Paired serology: IgM ELISA and MAT on convalescent sample 1
  2. Earliest MAT positives appear 6-10 days after symptom onset 1

Critical Pitfalls

Do not wait for laboratory confirmation to initiate treatment - treat upon clinical suspicion given the non-specific nature of initial investigations 1. Penicillin or doxycycline should be started during the bacteremic phase, though efficacy may be limited once jaundice develops 1.

Urine is NOT suitable for Leptospira isolation 1, despite the organism being excreted in urine.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.